The board of directors of K. H. Group Holdings Limited announced that Mr. Chen Rongsheng (Mr. Chen) has resigned as executive Director, with effect from 1 April 2023. The Board announced that Dr. Huang Yuan ("Dr. Huang"), Mr. Bu Youjun ("Mr. Bu") and Mr. Yang Xuefeng (Mr. Yang) have been appointed as executive Directors, all with effect from 1 April 2023. Set out below are their biographies.

Dr. Huang, aged 47, obtained his bachelor's degree in chemical engineering from Zhejiang University in June 1997. He further completed his doctoral degree in chemical engineering at Zhejiang University in March 2003. Dr. Huang was a lecturer at Zhejiang University and worked in research management at the university's science and technology office from 2003 to 2005.

From 2005 to 2021, he held various positions including the manager of organic peroxide technology development at ARKEMA (China) Investment Co. Ltd., the general manager of Hangzhou Greenda Chemical Co. Ltd., currently known as Hangzhou Greenda Electronic Materials Co.

Ltd., the deputy general manager of Hangzhou Jinjiang Group Company Ltd., and the president of Shanghai Haixin Group Co. Ltd., a company listed on the Shanghai Stock Exchange. He is currently the president of Haosheng Technology Group Co.

Ltd. and the chairman of the board of directors of Hengmei Optoelectronic Corporation. Dr. Huang has expertise in technical research and development as well as business management and has extensive experience in areas such as semiconductor display materials, new energy, and industrial manufacturing. Dr. Huang was appointed as an executive Director and the chairman of the Board with effect from 1 April 2023.

Mr. Bu, aged 47, obtained a bachelor's degree in commerce from University of Toronto in November 2001 and was awarded the fellow of the society of actuaries by the Society of Actuaries in February 2008. From 2002 to 2013, he held various positions including the senior actuarial assistant at Manulife Financial Corporation, a company listed on the Toronto Stock Exchange (stock code: MFC), New York Stock Exchange (stock code: MFC), the Stock Exchange (stock code: 945) and Philippine Stock Exchange (stock code: MFC), the assistant actuary at Sun Life Financial Inc., a company listed on the Toronto. Stock Exchange, the actuary at AXA Equitable Life Insurance Co.

(currently known as Equitable Holdings Inc., a company listed on the New York Stock Exchange) and the actuary and venture capital manager at HSBC Insurance (Asia) Limited. From 2011 to 2013, he was appointed as the director of financial risk management in the Asia-Pacific Region of FTLife Insurance Company Limited. In June 2015, Mr. Bu found China Elite (Hong Kong) Asset Management Company Limited and serves as the managing director since then.

Mr. Bu has over 20 years of extensive experience in actuarial analysis, risk management, investment, and capital operations, with particular expertise in empowering technology industries with financial support. Mr. Bu was appointed as an executive Director with effect from 1 April 2023. Mr. Yang, aged 32, obtained a bachelor's degree in logistics management from Dalian Maritime University in July 2012 and completed his Master of Business Administration (International) at the University of Hong Kong in December 2020.

From 2012 to 2019, Mr. Yang held various positions at HNA Group Co. Ltd.'s subsidiaries, including the project manager in the management department at Jin Hai Heavy Industry Co. Ltd., the investor relations manager at Tianjin Tianhai Investment Co.

Ltd. (currently known as HNA Technology Co. Ltd., a company listed on the Shanghai Stock Exchange, the head of capital operations center at HNA Innovative Finance Co. Ltd., and the assistant to the president at HNA Futures Co.

Ltd. . From July 2019 to February 2020, he worked as an investment director at Shanghai Silver Peak (Group) Co. Ltd. Mr. Yang currently serves as the secretary of the board of directors of Hengmei Optoelectronic Corporation.

Mr. Yang has extensive experience in project, investment, and management in areas such as supply chain, trade finance, new energy, and new materials. Mr. Yang was appointed as an executive Director with effect from 1 April 2023. The Board announced that subsequent to the resignation of Mr. Chen, Dr. Huang has been appointed as the chairman of the nomination committee of the Company with effect from 1 April 2023.

The Board announced that, with effect from 1 April 2023, Mr. Chen resigned as the chairman of the Board and Dr. Huang has been appointed as the chairman of the Board. Mr. Chen has resigned as authorised representative of the Company under the Listing Rules and Mr. Yang has been appointed as authorised representative of the Company under the Listing Rules, all with effect from 1 April 2023.